237 related articles for article (PubMed ID: 20009926)
1. Antiangiogenic agents in the treatment of nonsmall cell lung cancer: reality and hope.
Ramalingam SS; Belani CP
Curr Opin Oncol; 2010 Mar; 22(2):79-85. PubMed ID: 20009926
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic therapy in nonsmall cell lung cancer.
Gutierrez M; Giaccone G
Curr Opin Oncol; 2008 Mar; 20(2):176-82. PubMed ID: 18300767
[TBL] [Abstract][Full Text] [Related]
3. Emerging antiangiogenic therapies for non-small-cell lung cancer.
Blakely C; Jahan T
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1607-18. PubMed ID: 21999134
[TBL] [Abstract][Full Text] [Related]
4. Novel angiogenesis inhibitors in nonsmall cell lung cancer.
Reinmuth N; Heigener D; Reck M
Curr Opin Oncol; 2015 Mar; 27(2):79-86. PubMed ID: 25602682
[TBL] [Abstract][Full Text] [Related]
5. Targeting tumor neovasculature in non-small-cell lung cancer.
Pallis AG; Syrigos KN
Crit Rev Oncol Hematol; 2013 May; 86(2):130-42. PubMed ID: 23159217
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic therapies in non-small-cell lung cancer.
Alshangiti A; Chandhoke G; Ellis PM
Curr Oncol; 2018 Jun; 25(Suppl 1):S45-S58. PubMed ID: 29910647
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of Antiangiogenic Therapy Into the Non-Small-Cell Lung Cancer Paradigm.
Chu BF; Otterson GA
Clin Lung Cancer; 2016 Nov; 17(6):493-506. PubMed ID: 27381269
[TBL] [Abstract][Full Text] [Related]
8. Targeting angiogenesis in squamous non-small cell lung cancer.
Piperdi B; Merla A; Perez-Soler R
Drugs; 2014 Mar; 74(4):403-13. PubMed ID: 24578213
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis inhibitors and vascular disrupting agents in non-small cell lung cancer.
Rossi A; Maione P; Ferrara ML; Sacco PC; Schettino C; Bareschino MA; Gridelli C
Curr Med Chem; 2009; 16(30):3919-30. PubMed ID: 19747132
[TBL] [Abstract][Full Text] [Related]
10. Anti-Angiogenics: Their Value in Lung Cancer Therapy.
Janning M; Loges S
Oncol Res Treat; 2018; 41(4):172-180. PubMed ID: 29631257
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer.
Salgia R
Cancer; 2011 Sep; 117(17):3889-99. PubMed ID: 21858799
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic options targeting angiogenesis in nonsmall cell lung cancer.
Crinò L; Metro G
Eur Respir Rev; 2014 Mar; 23(131):79-91. PubMed ID: 24591665
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor receptor as target for advanced non-small cell lung cancer therapy.
Rossi A; Maione P; Sacco PC; Ambrosio R; Falanga M; Gridelli C
Curr Drug Targets; 2010 Jul; 11(7):865-8784. PubMed ID: 20412044
[TBL] [Abstract][Full Text] [Related]
14. Targeting the VEGF pathway: antiangiogenic strategies in the treatment of non-small cell lung cancer.
Aita M; Fasola G; Defferrari C; Brianti A; Bello MG; Follador A; Sinaccio G; Pronzato P; Grossi F
Crit Rev Oncol Hematol; 2008 Dec; 68(3):183-96. PubMed ID: 18606548
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis and antiangiogenic agents in non-small cell lung cancer.
Galligioni E; Ferro A
Lung Cancer; 2001 Dec; 34 Suppl 4():S3-7. PubMed ID: 11742695
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic agents in the management of non-small cell lung cancer: where do we stand now and where are we headed?
Aggarwal C; Somaiah N; Simon G
Cancer Biol Ther; 2012 Mar; 13(5):247-63. PubMed ID: 22481432
[TBL] [Abstract][Full Text] [Related]
17. Targeting angiogenesis with multitargeted tyrosine kinase inhibitors in the treatment of non-small cell lung cancer.
Scagliotti G; Govindan R
Oncologist; 2010; 15(5):436-46. PubMed ID: 20427383
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis inhibition in the treatment of lung cancer.
Vokes E; Herbst R; Sandler A
Clin Adv Hematol Oncol; 2006 Nov; 4(11 Suppl 23):1-10; quiz 11-2. PubMed ID: 17143257
[TBL] [Abstract][Full Text] [Related]
19. Emerging angiogenesis inhibitors for non-small cell lung cancer.
Malapelle U; Rossi A
Expert Opin Emerg Drugs; 2019 Jun; 24(2):71-81. PubMed ID: 31092048
[No Abstract] [Full Text] [Related]
20. Exploring the Benefit/Risk Associated with Antiangiogenic Agents for the Treatment of Non-Small Cell Lung Cancer Patients.
Kurzrock R; Stewart DJ
Clin Cancer Res; 2017 Mar; 23(5):1137-1148. PubMed ID: 27940520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]